Toubi; Elias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Toubi; Elias.The latest application filed is for "semaphorin 3a for treatment and prognosis of systemic lupus erythematosus".

Company Profile

0.4.5

Toubi; Elias - Haifa IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Semaphorin 3A for treatment and assessment of severity of inflammatory bowel disease Grant 10,736,939 - Vadasz , et al. A	2020-08-11
Semaphorin 3A for treatment and assessment of severity of Asthma Grant 10,568,932 - Vadasz , et al. Feb	2020-02-25
Semaphorin 3a For Treatment And Prognosis Of Systemic Lupus Erythematosus App 20190000921 - Vadasz; Zahava ; et al.	2019-01-03
Semaphorin 3A as a diagnostic marker for urothelial cancer Grant 10,139,412 - Vadasz , et al. Nov	2018-11-27
Semaphorin 3A for treatment of systemic lupus erythematosus Grant 10,105,413 - Vadasz , et al. October 23, 2	2018-10-23
Semaphorin 3a For Treatment And Assessment Of Severity Of Inflammatory Bowel Disease App 20180028604 - VADASZ; Zahava ; et al.	2018-02-01
Semaphorin 3a As A Diagnostic Marker For Urothelial Cancer App 20160299142 - VADASZ; Zahava ; et al.	2016-10-13
Semaphorin 3a For Treatment And Prognosis Of Systemic Lupus Erythematosus App 20160129079 - VADASZ; Zahava ; et al.	2016-05-12
Semaphorin 3a For Treatment And Assessment Of Severity Of Asthma App 20150216929 - Vadasz; Zahava ; et al.	2015-08-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.